United States · Bill · HR
H.R. 269 (116th)
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
Introduced
8 January 2019
Last action
10 January 2019 · Calendars
Status
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 10.
Sponsors
Rep. Eshoo, Anna G. [D-CA-18], Rep. Brooks, Susan W. [R-IN-5], Rep. DeGette, Diana [D-CO-1], Rep. Latta, Robert E. [R-OH-5], Rep. Dingell, Debbie [D-MI-6], Rep. Guthrie, Brett [R-KY-2], Rep. Pallone, Frank [D-NJ-6], Rep. Walden, Greg [R-OR-2]
Subjects
Healthcare, Defence
Source updated
28 May 2025
Summary
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 This bill (1) reauthorizes, revises, and establishes several programs and entities relating to public-health emergency preparedness and response; and (2) addresses the approval process for over-the counter (OTC) drugs. Among other programs, the bill reauthorizes through FY2023 and revises the Public Health Emergency Preparedness cooperative-agreement program administered by the Centers for Disease Control and Prevention (CDC), the Hospital Preparedness Program, the CDC situational-awareness and biosurveillance program, the Emergency System for Advance Registration of Volunteer Health Professionals, the National Disaster Medical System, the Volunteer Medical Reserve Corps, the National Advisory Committee on Children and Disasters, the Strategic National Stockpile, and the Biomedical Advanced Research and Development Authority. In addition, the bill provides statutory authority for existing programs, including the CDC's Children's Preparedness Unit and the Public Health Emergency Medical Countermeasures Enterprise. The bill also establishes new programs and entities, including a trauma-center grant program to support military trauma teams. The bill further modifies the approval process for OTC drugs by providing statutory authority for the Food and Drug Administration (FDA) to (1) regulate certain OTC drugs that are marketed without an approved new-drug application, and (2) issue administrative orders specifying the conditions under which an OTC drug may be deemed safe and effective and not subject to approval as a new drug. The FDA must assess and collect user fees for OTC drugs, including OTC-drug facility and OTC-drug order-request fees.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
8 January 2019
Passed
Motion to reconsider laid on the table Agreed to without objection.
Source: Floor
8 January 2019
Vote
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 401 - 17 (Roll no. 13). (text: CR H237-262)
Source: Floor
8 January 2019
Vote
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 401 - 17 (Roll no. 13).(text: CR H237-262)
Source: Floor
8 January 2019
Floor
Considered under suspension of the rules. (consideration: CR H237-266)
Source: Floor
8 January 2019
Vote
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Source: Floor
8 January 2019
Floor
DEBATE - The House proceeded with forty minutes of debate on H.R. 269.
Source: Floor
8 January 2019
Floor
Mr. Pallone moved to suspend the rules and pass the bill.
Source: Floor
8 January 2019
Introduced
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Homeland Security, Veterans' Affairs, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Source: IntroReferral
8 January 2019
Introduced
Introduced in House
Source: IntroReferral
8 January 2019
Introduced
Introduced in House
Source: IntroReferral
9 January 2019
Calendars
Received in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
Source: Calendars
10 January 2019
Calendars
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 10.
Source: Calendars
Votes
8 January 2019 · passed · On Motion to Suspend the Rules and Pass · Passed · Official source
Yes 401 · No 17 · Abstain — · Absent/not voting 15
- Rep. Ferguson, A. Drew, IV [R-GA-3]Yea
- Rep. McEachin, A. Donald [D-VA-4]Yea
- Rep. Hastings, Alcee L. [D-FL-20]Yea
- Rep. Finkenauer, Abby [D-IA-1]Yea
Showing the first 4 recorded positions. Vote totals above are complete.
Versions
- Placed on Calendar Senate · 10 January 2019 · Download file
- Engrossed in House · 8 January 2019 · Download file
Documents
6 official files
Placed on Calendar Senate (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Placed on Calendar Senate (text)
Placed on Calendar Senate · EN · 10 January 2019
Placed on Calendar Senate (PDF)
Placed on Calendar Senate · EN · 10 January 2019
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Engrossed in House (text)
Engrossed in House · EN · 8 January 2019
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Engrossed in House (PDF)
Engrossed in House · EN · 8 January 2019
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Passed House
summary · EN · 8 January 2019
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 8 January 2019
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Eshoo, Anna G. [D-CA-18] · D · Sponsor
- Rep. Brooks, Susan W. [R-IN-5] · R · Sponsor
- Rep. DeGette, Diana [D-CO-1] · D · Sponsor
- Rep. Latta, Robert E. [R-OH-5] · R · Sponsor
- Rep. Dingell, Debbie [D-MI-6] · D · Sponsor
- Rep. Guthrie, Brett [R-KY-2] · R · Sponsor
- Rep. Pallone, Frank [D-NJ-6] · D · Sponsor
- Rep. Walden, Greg [R-OR-2] · R · Sponsor
- · hsju00 · Standing
- · hsvr00 · Standing
- · hshm00 · Standing
- · hsif00 · Standing
Related records
- related to → Strengthening the National Disaster Medical System Act of 2019
- related to ← SMASH Act
- related to ← Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
- related to ← To clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved drug application, and for other purposes.
- related to ← Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2019
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/269
- Open data entity: https://api.congress.gov/v3/bill/116/hr/269
- us · 116-hr-269 · source updated 28 May 2025